Welcome to our dedicated page for Fuller H B news (Ticker: FUL), a resource for investors and traders seeking the latest updates and insights on Fuller H B stock.
H.B. Fuller Company reports developments in its global adhesives, sealants and functional coatings business under NYSE symbol FUL. News commonly covers quarterly and annual results, gross margin trends, pricing and raw-material cost actions, dividends on common stock, and portfolio or footprint initiatives tied to Project Quantum Leap.
The company serves packaging, converting, hygiene, health and beauty, construction, engineering and aerospace-related applications through specialty industrial adhesive technologies. Updates also include manufacturing investments, supply-continuity actions, and customer support for regulated markets such as aviation, space and defense.
H.B. Fuller (NYSE: FUL) announced a strategic investment in VerdaFresh, an advanced oxygen barrier coating that strengthens its sustainable packaging portfolio.
The proprietary, recycler-friendly technology enables mono-material, fully recyclable packaging structures, removes the need for EVOH and other hard-to-recycle layers, and aims to cut waste, materials use, and carbon impact while maintaining product shelf life.
H.B. Fuller (NYSE: FUL) outlined its value creation and M&A strategy. The company targets adjusted EBITDA margins >20%, low-teens ROIC and strong cash flow conversion as it pivots toward higher-margin specialty adhesives.
Since early 2023, H.B. Fuller has executed 13 acquisitions. In the U.K., four deals since 2022 expanded acquired adjusted EBITDA from $30 million at ~13% margin to over $60 million at >23% margin in three years. Net debt to adjusted EBITDA fell to 3.1x at Q1-end from 3.5x a year earlier. The company is in discussions regarding Advanced Medical Solutions Group but notes there is no certainty a binding offer will be made.
Ancora Holdings Group, owning over 2% of H.B. Fuller (NYSE: FUL), released a letter opposing H.B. Fuller’s attempt to acquire U.K.-based Advanced Medical Solutions (AMS). Ancora argues the transaction would raise leverage above 4.0x Net Debt / Proforma Adjusted EBITDA, worsen the company’s valuation multiple and contradict prior deleveraging commitments.
Ancora urges the board to abandon the AMS pursuit and instead initiate a full review of strategic alternatives, including potential sale options, citing H.B. Fuller’s trading discount and what it believes is meaningful acquirer interest.
H.B. Fuller (NYSE: FUL) announced a new Aerospace Manufacturing Center of Excellence in Charlotte, N.C., expected to open in early 2027. The purpose-built facility will consolidate specialized manufacturing, packaging, testing, and quality operations into a single site engineered for aerospace requirements.
The center aims to expand capacity, support long qualification timelines, enhance quality and reliability, and join the company’s aerospace-accredited network. H.B. Fuller expects AS9100 certification and plans to pursue Nadcap accreditation.
H.B. Fuller (NYSE: FUL) raised its regular quarterly cash dividend from $0.2350 to $0.2450 per share, a 4.3% increase. The dividend is payable on May 14, 2026 to shareholders of record at the close of business on April 30, 2026.
The company has paid quarterly cash dividends for 58 consecutive years, continuing its long-standing shareholder distribution policy.
H.B. Fuller (NYSE: FUL) reported Q1 2026 results: net revenue $771 million, organic revenue down 6.6% and reported net income of $21 million. Adjusted EBITDA was $119 million (+4%), adjusted EBITDA margin 15.4% (+90 bps), and adjusted EPS was $0.57 (+6%).
The company raised fiscal 2026 guidance: net revenue now expected up mid-single digits; adjusted EBITDA $645–$675 million; adjusted EPS $4.55–$4.90. Net debt was $1,968 million (net debt/adjusted EBITDA 3.1X).
H.B. Fuller (NYSE: FUL) will implement a global minimum 10% price increase across all product lines effective April 1, 2026, with larger increases for certain technologies and regions. The action responds to petrochemical industry constraints that are affecting raw material availability and costs.
The company says it is securing materials early, reallocating supply regionally and qualifying alternative materials to maintain customer continuity and service while investing in operational resilience.
H.B. Fuller (NYSE: FUL) will report results for the three-month fiscal period ended February 28, 2026 in a press release after market close on March 25, 2026. The company will host an investor conference call on March 26, 2026 at 9:30 a.m. CT (10:30 a.m. ET).
Investors may listen via a live webcast with a supplemental presentation at the company investor website; registration is required. A telephone replay will be available from 12:30 p.m. CT on March 26 through 10:59 p.m. CT on April 2, 2026 using Conference ID 6370505.
H.B. Fuller (NYSE: FUL) announced a regular quarterly cash dividend of $0.2350 per share, payable on February 19, 2026 to shareholders of record at the close of business on February 5, 2026. The company has paid quarterly cash dividends on its common stock for 58 consecutive years.
H.B. Fuller (NYSE: FUL) reported Q4 2025 net revenue of $895M and net income of $30M, with adjusted EBITDA of $170M (up 14.6% YoY) and adjusted EPS of $1.28 (up 39.1% YoY). Fiscal 2025 net revenue was $3.47B and adjusted EBITDA $621M (up 4.5% YoY) with adjusted EPS of $4.24 (up 10.4% YoY). Adjusted gross margin expanded and adjusted EBITDA margin reached 17.9% for FY 2025. Net debt was $1.91B (net debt/adjusted EBITDA 3.1x). Fiscal 2026 outlook: net revenue flat to +2% and adjusted EBITDA of $630M–$660M.